CVRx (CVRX) EBIT Growth (1y) (2021 - 2026)
CVRx (CVRX) EBIT Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | -17.50% |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 49.06% |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 43.83% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 24.81% |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 49.72% |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 13.00% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 57.74% |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 16.18% |
| 10 | CVRx | 76.50 Mn | 11.91 Mn | 13.72 Mn | 9.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.41% |
| Mar 31, 2026 | 9.50% |
| Dec 31, 2025 | -8.86% |
| Sep 30, 2025 | 5.71% |
| Jun 30, 2025 | -2.88% |
| Mar 31, 2025 | 39.56% |
| Dec 31, 2024 | -6.35% |
| Sep 30, 2024 | -36.56% |
| Jun 30, 2024 | -18.90% |
| Mar 31, 2024 | -82.80% |
| Dec 31, 2023 | 15.84% |
| Sep 30, 2023 | 5.91% |
| Jun 30, 2023 | -6.70% |
| Mar 31, 2023 | -22.75% |
| Dec 31, 2022 | -30.62% |
| Sep 30, 2022 | -38.88% |
| Jun 30, 2022 | -94.18% |
| Mar 31, 2022 | -134.95% |
| Dec 31, 2021 | -311.62% |
| Sep 30, 2021 | -139.68% |